Testing a new weight-loss drug for people who had stomach issues with orlistat
Part of Hormones & metabolism clinical trials.
This trial tests a new weight-loss drug that may be easier on your stomach than current options. If you had bothersome digestive side effects with orlistat or this drug before, this study checks whether a different version works better for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have had stomach or bowel issues (like oily spotting, leaking, or severe diarrhea) with this study drug or with the weight-loss drug orlistat in the past.
- You must be at least 18 years old.
- You must have a BMI of 30 or higher, or a BMI of 27 or higher along with another condition like high blood pressure, prediabetes, type 2 diabetes (diet-controlled), or high cholesterol.
- You must have normal kidney and liver function (checked by blood tests).
- You must not be taking any other weight-loss medication, and you cannot have type 2 diabetes requiring medication.
- You must not have serious digestive diseases (like IBS, inflammatory bowel disease) or a history of stomach/weight-loss surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medication called IBI3046 for people who are overweight or have obesity. The purpose is to see if it helps with weight loss and works safely.
This trial tests an experimental medication that may help with weight loss. It aims to see how safe the drug is and how the body responds, possibly leading to a new treatment option for obesity.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study tests an experimental drug called IBI3042 in healthy people who are normal weight, overweight, or obese. It is an early-stage trial looking at how safe and tolerable the drug is, and how it affects the body, which could eventually lead to a treatment for weight loss.
This study tests a new drug called BI 3034701 to see how well people tolerate different doses. It may help with weight loss and related health issues.
This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.
Hear when a new Overweight or Obese trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.